Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
28,532,796
-
Share change
-
+674,652
-
Total reported value
-
$1,100,883,608
-
Put/Call ratio
-
51%
-
Price per share
-
$38.58
-
Number of holders
-
146
-
Value change
-
+$34,445,813
-
Number of buys
-
78
-
Number of sells
-
58
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2015
As of 31 Dec 2015,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,532,796 shares.
The largest 10 holders included
VANGUARD GROUP INC, Point72 Asset Management, L.P., FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, and JENNISON ASSOCIATES LLC.
This page lists
146
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.